Civic Intelligence

Altius Institute for Biomedical Sciences

990 • Fiscal year 2018 • EIN 47-2231080

Jan 01, 2018 to Dec 31, 2018 • Filed on Jan 24, 2020

2211 Elliott Avenue No 410Seattle, WA 98121

(206) 267-1091

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

66th percentile

0.39x

Higher debt load relative to assets than 66% of similar nonprofits.

2018 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2018

Liabilities / Revenue

60th percentile

0.36x

Higher debt load relative to revenue than 60% of similar nonprofits.

2018 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2018

Net Margin

17th percentile

-8.8%

Higher net margin than 17% of similar nonprofits.

2018 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2018

Top Officer Pay

95th percentile

$790,032

Higher top officer pay than 95% of similar nonprofits.

Top officer pay equals 3.7% of source-year revenue.

2018 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2018

Asset Growth

2nd percentile

-26%

Faster asset growth than 2% of similar nonprofits.

2018 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2017 to 2018

Revenue Growth

23rd percentile

-5.9%

Faster revenue growth than 23% of similar nonprofits.

2018 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2017 to 2018

Assets

Down

$19,497,322

Down $6,861,667 (-26%) from 2017

Net Assets

Down

$11,845,618

Down $1,889,168 (-14%) from 2017

Liabilities

Down

$7,651,704

Down $4,972,499 (-39%) from 2017

Revenue

Down

$21,469,277

Down $1,352,284 (-5.9%) from 2017

Expenses

Up

$23,358,445

Up $1,491,964 (+6.8%) from 2017

Net Income

Down

-$1,889,168

Down $2,844,248 (-298%) from 2017

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$80M$60M$40M$20M$0Assets 2016: $21,682,398Liabilities 2016: $8,902,692Net Assets 2016: $12,779,7062016Assets 2017: $26,358,989Liabilities 2017: $12,624,203Net Assets 2017: $13,734,7862017Assets 2018: $19,497,322Liabilities 2018: $7,651,704Net Assets 2018: $11,845,6182018Assets 2019: $17,764,328Liabilities 2019: $9,778,672Net Assets 2019: $7,985,6562019Assets 2020: $20,723,085Liabilities 2020: $8,197,072Net Assets 2020: $12,526,0132020Assets 2021: $61,078,390Liabilities 2021: $37,458,008Net Assets 2021: $23,620,3822021Assets 2022: $39,729,559Liabilities 2022: $13,226,158Net Assets 2022: $26,503,4012022Assets 2024: $17,386,206Liabilities 2024: $7,754,901Net Assets 2024: $9,631,3052024

Highlighted filing

2018

Assets$19,497,322
Liabilities$7,651,704
Net Assets$11,845,618

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$60M$40M$20M$0-$20MRevenue 2016: $27,959,116Expenses 2016: $20,271,920Net Income 2016: $7,687,1962016Revenue 2017: $22,821,561Expenses 2017: $21,866,481Net Income 2017: $955,0802017Revenue 2018: $21,469,277Expenses 2018: $23,358,445Net Income 2018: -$1,889,1682018Revenue 2019: $16,965,373Expenses 2019: $20,825,335Net Income 2019: -$3,859,9622019Revenue 2020: $25,217,625Expenses 2020: $22,201,302Net Income 2020: $3,016,3232020Revenue 2021: $44,158,765Expenses 2021: $33,064,396Net Income 2021: $11,094,3692021Revenue 2022: $55,346,565Expenses 2022: $54,165,332Net Income 2022: $1,181,2332022Revenue 2024: $25,521,018Expenses 2024: $32,275,657Net Income 2024: -$6,754,6392024

Highlighted filing

2018

Revenue$21,469,277
Expenses$23,358,445
Net Income-$1,889,168
Jump To
Filing Snapshot
Filing Period
Jan 1, 2018 to Dec 31, 2018
Signed
Jan 24, 2020
Return Version
2018v3.1
Gross Receipts
$21,469,277
Mission and Program Overview

Mission

The mission of the altius institute for biomedical sciences (altius) is to radically enable and advance biomedical discovery through the development and exploratory application of new technologies and approaches for illuminating cell and tissue states and function. To achieve this vision, altius is establishing a wholly new type of scientific and technological discovery environment designed to foster leaps in innovation. Altius will leverage its cutting-edge technologies to span the chasm between basic biological discoveries related to the function of cells and tissues and the translation of these insights into the clinical arena and the development of novel medicines.

To radically enable and advance biomedical discovery through the development and exploratory application of new technologies and approaches for illuminating cell and tissue states and function. To achieve this vision, altius is establishing a wholly new type of scientific and technological discovery environment designed to foster leaps in innovation. Altius will leverage its cutting-edge technologies to span the chasm between basic biological discoveries related to the function of cells and tissues and the translation of these insights into the clinical arena and the development of novel medicines.

Balance Sheet Detail
LineBeginningEndChange
Assets
Land, Buildings, and Equipment, Net$13,284,611$11,331,858▼ $1,952,753
Accounts Receivable$2,839,353$4,677,505▲ $1,838,152
Savings and Temporary Cash Investments$2,086,343$2,091,249▲ $4,906
Cash and Non-Interest-Bearing Accounts$7,166,211$1,010,997▼ $6,155,214
Prepaid Expenses and Deferred Charges$193,546$348,788▲ $155,242
Loans From Officers Directors-$100,000-
Intangible Assets$23,725$23,725→ $0
Total Assets$26,358,989$19,497,322▼ $6,861,667
Other Assets Total$765,200$13,200▼ $752,000
Liabilities
Accounts Payable and Accrued Expenses$3,949,077$4,875,811▲ $926,734
Other Liabilities$2,017,541$1,100,000▼ $917,541
Mortgage Notes Payable Secured by Investment Property$6,141,262$1,071,136▼ $5,070,126
Deferred Revenue$516,323$504,757▼ $11,566
Total Liabilities$12,624,203$7,651,704▼ $4,972,499
Net Assets / Fund Balance
Unrestricted Net Assets$13,734,786$11,845,618▼ $1,889,168
Total Net Assets Fund Balance$13,734,786$11,845,618▼ $1,889,168
Total Liabilities and Net Assets / Fund Balance$26,358,989$19,497,322▼ $6,861,667

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$3,050,792$5,794,044$8,844,836
Leasehold Improvements$7,231,643$1,569,438$8,801,081
Other Land Buildings$1,049,423$69,933$1,119,356
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
John StamatoyannopoulosPresident/scientific DirectorFT$750,000$40,032$790,032
Fyodor UrnovAssociate DirectorFT$458,072$31,220$489,292
Michael CockrilChief Technology OfficerFT$319,858$61,785$381,643
Jeff VierstraPrincipal InvestigatorFT$232,114$45,969$278,083
Wouter MeulemanPrincipal InvestigatorFT$222,878$50,510$273,388
Tim MercerPrincipal InvestigatorFT$223,042$31,195$254,237
Lori Tonnes-priddySecretary-$115,920$10,757$126,677
Hal DietzBoard Member-$15,000-$15,000
Peter HandrinosBoard Member-$15,000-$15,000

Board Members and Trustees

NameTitle
Carolyn Buser-doepnerBoard Member
Tony WoodBoard Member

Highest Paid Contractors

ContractorServicesLocationCompensation
Dovetail General ContractorsConstruction Contracters1143 NW 45TH STREET, Seattle, WA 98107$350,913
Keith GrochowSoftware Development1425 BROADWAY, Seattle, WA 98122$135,000
Tonnes PllcLegal Services18728 33RD AVE SE, Bothell, WA 98012$110,297
Revenue and Support

Revenue Composition

Contributions and Grants
$21,464,371
Program Service Revenue
$0
Investment Income
$4,906
Other Revenue
$0
All Other Contributions
$14,973,633
Change in Net Assets
$-1,889,168

Audited Revenue Reconciliation

Revenue per Audited Statements
$21,469,277
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$0
Total Revenue per Audited Statements
$21,469,277
Total Revenue per Form 990
$21,469,277
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$11,674,185
Salaries, Compensation, and Employee Benefits$11,578,096
Grants and Similar Amounts Paid$106,164
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$6,813,532$1,489,000-$8,302,532
Depreciation Depletion$2,449,106$274,256-$2,723,362
Occupancy$1,409,793$570,320-$1,980,113
Fees for Services Other$756,313$1,176,565-$1,932,878
Other Employee Benefits$1,328,912$343,987-$1,672,899
Current Officers, Directors, Trustees, and Key Employees$664,226$282,483-$946,709
Payroll Taxes$565,250$90,706-$655,956
Information Technology$338,168$84,542-$422,710
Travel$322,544$64,046-$386,590
Interest-$335,084-$335,084
Office Expenses$121,460$91,844-$213,304
Foreign Grants$106,164--$106,164
Conferences and Meetings$74,979$2,500-$77,479
Other Expenses$574,915$74,241-$74,241
Insurance-$67,385-$67,385
All Other Expenses-$27,282-$27,282
Advertising-$753-$753
Total Functional Expenses$18,383,451$4,974,994$0$23,358,445

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$23,358,445
Total Expenses per Audited Statements$23,358,445
Total Expenses per Form 990$23,358,445
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

International Summary

Offices
0
Employees
0
Spending
$106,164

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Europe (including Iceland & Greenland) - Albania, Andorra, Austria, BelgiumFundraising-00$106,164
Europe (including Iceland & Greenland)Grants to Recipients Located in the Region-00-
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
Tonnes Pllc35%+ OWNED ENTITY OF LORI TONNES-PRIDDY, OFFICER OF THE ORGANIZATIONLegal ServicesNo$110,297

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees-$100,000-
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Lease Incentive Obligation, Net$864,242
Deferred Rent$197,399
Capital Lease Obligation$38,359
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with family members
No
Business relationship with organization members
Yes
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
Yes
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 6

The organization has one class of membership which includes two members, dr. John stamatoyannopoulos (or his designee) and glaxosmithkline llc.

Form 990, Part VI, Section A, Line 7A

The members of the organization are entitled to elect directors of the board and remove only directors which they have appointed.

Form 990, Part VI, Section A, Line 7B

The glaxosmithkline llc member may elect and remove glaxosmithkline llc directors of the board while john stamatoyannopoulos as a member may elect and remove john stamatoyannopoulos directors of the board. Common directors of the board are elected and removed by unanimous action of john stamatoyannopoulos and glaxosmithkline llc members.

Form 990, Part VI, Section B, Line 11B

The president/scientific director will review the form 990 prior to its submission to the irs.

Form 990, Part VI, Section B, Line 12C

The organization's conflict of interest policy requires covered persons, defined as any director, officer, or member of a committee of the board of directors, to complete and sign an annual conflict of interest questionnaire. The questionnaire requires disclosure of any potential or actual conflicts of interest and is signed by the covered person, affirming that the individual has received a copy of, read, understands, and will comply with the organization's conflict of interest policy. If a potential or actual conflict of interest arises, the individual must recuse himself or herself from voting on the matter and must not be present when any such vote is taken. The board of directors evaluates all disclosures reported to determine whether an actual conflict of interest exists. Potential or actual conflicts of interest are documented in the minutes of meetings of the board of directors and committee's of the board.

Form 990, Part VI, Section B, Line 15

A compensation study was conducted by an outside consultant in 2018 to determine the compensation for the president, deputy director, and cto. The compensation study was approved by the board of directors. The study is effective through 2019. The next study is in the process of being compiled.

Form 990, Part VI, Section C, Line 19

The governing documents, conflict of interest policy and financial statements are made available to the public upon request.

Filing and Contact Details

Filer

Filer Name
Altius Institute for Biomedical Sciences
EIN
47-2231080
Phone
2062671091
Address
2211 ELLIOTT AVENUE NO 410, SEATTLE, WA 98121

Signing Officer

Name
John Stamatoyannopoulos
Title
President/scientific Director
Phone
2062671091
Signed
2020-01-24
Discuss with paid preparer
Yes

Organization Details

Principal Officer
John Stamatoyannopoulos
Formed
2014
Legal Domicile
De
Voting Board Members
4
Independent Board Members
3
Employees
97
Volunteers
2

Preparer

Firm
Clark Nuber Ps
Address
10900 NE 4TH STREET SUITE 1400, BELLEVUE, WA 98004
Preparer
Sara Elizabeth J Hyre
Phone
4244544919
Supplemental Narrative

Additional Explanations

PART IX, FUNCTIONAL EXPENSE ALLOCATION:

All expenses associated with obtaining grants are included in program and general and administrative expenses as allowed under the indirect cost recovery provisions of the grant agreement.

Raw XML AppendixShowing 400 of 635 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt03949077
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt04875811
IRS990/AccountsReceivableGrp/BOYAmt02839353
IRS990/AccountsReceivableGrp/EOYAmt04677505
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0TO RADICALLY ENABLE AND ADVANCE BIOMEDICAL DISCOVERY THROUGH THE DEVELOPMENT AND EXPLORATORY APPLICATION OF NEW TECHNOLOGIES AND APPROACHES FOR ILLUMINATING CELL AND TISSUE STATES AND FUNCTION. TO ACHIEVE THIS VISION, ALTIUS IS ESTABLISHING A WHOLLY NEW TYPE OF SCIENTIFIC AND TECHNOLOGICAL DISCOVERY ENVIRONMENT DESIGNED TO FOSTER LEAPS IN INNOVATION. ALTIUS WILL LEVERAGE ITS CUTTING-EDGE TECHNOLOGIES TO SPAN THE CHASM BETWEEN BASIC BIOLOGICAL DISCOVERIES RELATED TO THE FUNCTION OF CELLS AND TISSUES AND THE TRANSLATION OF THESE INSIGHTS INTO THE CLINICAL ARENA AND THE DEVELOPMENT OF NOVEL MEDICINES.
IRS990/AdvertisingGrp/ManagementAndGeneralAmt0753
IRS990/AdvertisingGrp/TotalAmt0753
IRS990/AllOtherContributionsAmt014973633
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt027282
IRS990/AllOtherExpensesGrp/TotalAmt027282
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/PersonNm0LISA JENNESS
IRS990/BooksInCareOfDetail/PhoneNum02062671091
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt02211 ELLIOTT AVENUE SUITE 410
IRS990/BooksInCareOfDetail/USAddress/CityNm0SEATTLE
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0WA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd098121
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd01
IRS990/CashNonInterestBearingGrp/BOYAmt07166211
IRS990/CashNonInterestBearingGrp/EOYAmt01010997
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt03
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0282483
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0664226
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0946709
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt02500
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt074979
IRS990/ConferencesMeetingsGrp/TotalAmt077479
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContractorCompensationGrp/CompensationAmt0350913
IRS990/ContractorCompensationGrp/CompensationAmt1135000
IRS990/ContractorCompensationGrp/CompensationAmt2110297
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt01143 NW 45TH STREET
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt11425 BROADWAY
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt218728 33RD AVE SE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0SEATTLE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1SEATTLE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm2BOTHELL
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0WA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1WA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd2WA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd098107
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd198122
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd298012
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0DOVETAIL GENERAL CONTRACTORS
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1KEITH GROCHOW
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt2TONNES PLLC
IRS990/ContractorCompensationGrp/ServicesDesc0CONSTRUCTION CONTRACTERS
IRS990/ContractorCompensationGrp/ServicesDesc1SOFTWARE DEVELOPMENT
IRS990/ContractorCompensationGrp/ServicesDesc2LEGAL SERVICES
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt021464371
IRS990/CYGrantsAndSimilarPaidAmt0106164
IRS990/CYInvestmentIncomeAmt04906
IRS990/CYOtherExpensesAmt011674185
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-1889168
IRS990/CYSalariesCompEmpBnftPaidAmt011578096
IRS990/CYTotalExpensesAmt023358445
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt021469277
IRS990/DecisionsSubjectToApprovaInd01
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt0516323
IRS990/DeferredRevenueGrp/EOYAmt0504757
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0274256
IRS990/DepreciationDepletionGrp/ProgramServicesAmt02449106
IRS990/DepreciationDepletionGrp/TotalAmt02723362
IRS990/Desc0ALTIUS DIRECTLY CONDUCTS AN ACTIVE AND MULTIFACETED PROGRAM OF BIOTECHNOLOGY RESEARCH. WE CONDUCT A CONSIDERABLE MAJORITY OF RESEARCH PROGRAMS DIRECTLY IN OUR OWN RESEARCH LABORATORY FACILITY, LOCATED IN SEATTLE. THE MEDICAL RESEARCH ORGANIZATION PROGRAM IS INTENDED TO GENERATE, DEVELOP AND TRANSLATE TO CLINICAL USE REGULATORY GENOMIC AND OTHER TECHNOLOGIES THAT HAVE TRANSFORMATIVE POTENTIAL IN BASIC BIOLOGY, BIOMEDICINE AND PHARMACEUTICAL DEVELOPMENT AND VALIDATION. INITIAL EFFORTS OF OUR RESEARCH PROGRAM FOCUS ON DEVELOPING A RICHER UNDERSTANDING OF HUMAN CELL MODELS, TARGETS AND MECHANISMS, FOR THE PURPOSE OF DEVELOPING NEW THERAPIES FOR DISEASE. TO THIS END, THE ORGANIZATION WILL FOCUS DEVELOPMENT ON DRIVING THE SCALING AND TRANSLATIONAL VALIDATION OF EXISTING CUTTING EDGE RESEARCH PLATFORMS, INCLUDING REGULATORY GENOMIC ANALYSES AND GENOME ENGINEERING TECHNOLOGIES. REGULATORY GENOMIC ANALYSIS YIELDS A HIGH-CONTENT, QUANTITATIVE ASSESSMENT OF INDIVIDUAL REGULATORY ELEMENTS, WHICH PROVIDES HIGHLY SENSITIVE MARKERS OF CELLULAR RESPONSE TO DISEASE AND TO CURRENT AND PAST DRUG EXPOSURES. SUCH ASSESSMENTS INFORM WHAT TISSUE AND TARGET TO STUDY, HOW TO MODULATE A DRUG TARGET, ANTICIPATE OFF-TARGET EFFECTS, AND PROTOTYPE DRUG TREATMENT EFFECTS.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt097
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt018383451
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditPerformedInd01
IRS990/FederalGrantAuditRequiredInd01
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt01176565
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0756313
IRS990/FeesForServicesOtherGrp/TotalAmt01932878
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt0106164
IRS990/ForeignGrantsGrp/TotalAmt0106164
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt54.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt640.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt740.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt840.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1040.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt040032
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt510757
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt631220
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt761785
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt845969
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt931195
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1050510
IRS990/Form990PartVIISectionAGrp/PersonNm0JOHN STAMATOYANNOPOULOS
IRS990/Form990PartVIISectionAGrp/PersonNm1PETER HANDRINOS
IRS990/Form990PartVIISectionAGrp/PersonNm2HAL DIETZ
IRS990/Form990PartVIISectionAGrp/PersonNm3TONY WOOD
IRS990/Form990PartVIISectionAGrp/PersonNm4CAROLYN BUSER-DOEPNER
IRS990/Form990PartVIISectionAGrp/PersonNm5LORI TONNES-PRIDDY
IRS990/Form990PartVIISectionAGrp/PersonNm6FYODOR URNOV
IRS990/Form990PartVIISectionAGrp/PersonNm7MICHAEL COCKRIL
IRS990/Form990PartVIISectionAGrp/PersonNm8JEFF VIERSTRA
IRS990/Form990PartVIISectionAGrp/PersonNm9TIM MERCER
IRS990/Form990PartVIISectionAGrp/PersonNm10WOUTER MEULEMAN
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0750000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt115000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt215000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt5115920
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt6458072
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt7319858
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt8232114
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9223042
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10222878
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT/SCIENTIFIC DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt2BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt3BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt4BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt5SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt6ASSOCIATE DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7CHIEF TECHNOLOGY OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt8PRINCIPAL INVESTIGATOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9PRINCIPAL INVESTIGATOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10PRINCIPAL INVESTIGATOR
IRS990/Form990ProvidedToGvrnBodyInd00
IRS990/FormationYr02014
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt04
IRS990/GovernmentGrantsAmt06490738
IRS990/GrantAmt0106164
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt021469277
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt03
IRS990/IndivRcvdGreaterThan100KCnt030
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt084542
IRS990/InformationTechnologyGrp/ProgramServicesAmt0338168
IRS990/InformationTechnologyGrp/TotalAmt0422710
IRS990/InsuranceGrp/ManagementAndGeneralAmt067385
IRS990/InsuranceGrp/TotalAmt067385
IRS990/IntangibleAssetsGrp/BOYAmt023725
IRS990/IntangibleAssetsGrp/EOYAmt023725
IRS990/InterestGrp/ManagementAndGeneralAmt0335084
IRS990/InterestGrp/TotalAmt0335084
IRS990/InvestmentIncomeGrp/ExclusionAmt04906
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt04906
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt026
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt07433415
IRS990/LandBldgEquipBasisNetGrp/BOYAmt013284611
IRS990/LandBldgEquipBasisNetGrp/EOYAmt011331858
IRS990/LandBldgEquipCostOrOtherBssAmt018765273
IRS990/LegalDomicileStateCd0DE
IRS990/LoanOutstandingInd01
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt0100000
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd01
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE MISSION OF THE ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES (ALTIUS) IS TO RADICALLY ENABLE AND ADVANCE BIOMEDICAL DISCOVERY THROUGH THE DEVELOPMENT AND EXPLORATORY APPLICATION OF NEW TECHNOLOGIES AND APPROACHES FOR ILLUMINATING CELL AND TISSUE STATES AND FUNCTION. TO ACHIEVE THIS VISION, ALTIUS IS ESTABLISHING A WHOLLY NEW TYPE OF SCIENTIFIC AND TECHNOLOGICAL DISCOVERY ENVIRONMENT DESIGNED TO FOSTER LEAPS IN INNOVATION. ALTIUS WILL LEVERAGE ITS CUTTING-EDGE TECHNOLOGIES TO SPAN THE CHASM BETWEEN BASIC BIOLOGICAL DISCOVERIES RELATED TO THE FUNCTION OF CELLS AND TISSUES AND THE TRANSLATION OF THESE INSIGHTS INTO THE CLINICAL ARENA AND THE DEVELOPMENT OF NOVEL MEDICINES.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/MortgNotesPyblScrdInvstPropGrp/BOYAmt06141262
IRS990/MortgNotesPyblScrdInvstPropGrp/EOYAmt01071136
IRS990/NetAssetsOrFundBalancesBOYAmt013734786
IRS990/NetAssetsOrFundBalancesEOYAmt011845618
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt0570320
IRS990/OccupancyGrp/ProgramServicesAmt01409793
IRS990/OccupancyGrp/TotalAmt01980113
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt091844
IRS990/OfficeExpensesGrp/ProgramServicesAmt0121460
IRS990/OfficeExpensesGrp/TotalAmt0213304
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0765200
IRS990/OtherAssetsTotalGrp/EOYAmt013200
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt0343987
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt01328912
IRS990/OtherEmployeeBenefitsGrp/TotalAmt01672899
IRS990/OtherExpensesGrp/Desc0LAB SUPPLIES
IRS990/OtherExpensesGrp/Desc1RESEARCH COLLABORATIONS
IRS990/OtherExpensesGrp/Desc2RESEARCH & DEVELOPMENT
IRS990/OtherExpensesGrp/Desc3BUSINESS TAX & LICENSES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt074241
IRS990/OtherExpensesGrp/ProgramServicesAmt01786880
IRS990/OtherExpensesGrp/ProgramServicesAmt11071209
IRS990/OtherExpensesGrp/ProgramServicesAmt2574915
IRS990/OtherExpensesGrp/TotalAmt01786880
IRS990/OtherExpensesGrp/TotalAmt11071209
IRS990/OtherExpensesGrp/TotalAmt2574915
IRS990/OtherExpensesGrp/TotalAmt374241
IRS990/OtherLiabilitiesGrp/BOYAmt02017541
IRS990/OtherLiabilitiesGrp/EOYAmt01100000
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt01489000
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt06813532
IRS990/OtherSalariesAndWagesGrp/TotalAmt08302532
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt090706
IRS990/PayrollTaxesGrp/ProgramServicesAmt0565250
IRS990/PayrollTaxesGrp/TotalAmt0655956
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0193546
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0348788
IRS990/PrincipalOfficerNm0JOHN STAMATOYANNOPOULOS
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt022820619
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt0942
IRS990/PYOtherExpensesAmt010714810
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0955080
IRS990/PYSalariesCompEmpBnftPaidAmt011151671
IRS990/PYTotalExpensesAmt021866481
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt022821561
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-1889168
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt02086343
IRS990/SavingsAndTempCashInvstGrp/EOYAmt02091249
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm0BOSTON
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm1NEW HAVEN
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd0MA
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd1CT
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt0BRIGHAM AND WOMEN'S HOSPITAL
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt1YALE SCHOOL OF MEDICINE
IRS990ScheduleA/MedicalResearchOrganizationInd0X
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/EquipmentGrp/BookValueAmt03050792
IRS990ScheduleD/EquipmentGrp/DepreciationAmt05794044
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt08844836
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt023358445
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt07231643
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt01569438
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt08801081
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt01049423
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt069933
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt01119356
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt0197399
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt138359
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt2864242
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0DEFERRED RENT
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1CAPITAL LEASE OBLIGATION
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc2LEASE INCENTIVE OBLIGATION, NET
IRS990ScheduleD/RevenueNotReportedAmt00
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt00
IRS990ScheduleD/RevenueSubtotalAmt021469277
IRS990ScheduleD/TotalBookValueLandBuildingsAmt011331858
IRS990ScheduleD/TotalExpensesPerForm990Amt023358445
IRS990ScheduleD/TotalLiabilityAmt01100000
IRS990ScheduleD/TotalRevenuePerForm990Amt021469277
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt021469277
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt023358445
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt0106164
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt1EUROPE (INCLUDING ICELAND & GREENLAND)
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0FUNDRAISING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt1GRANTS TO RECIPIENTS LOCATED IN THE REGION
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt00
IRS990ScheduleF/ContinuationTotalEmployeeCnt00
IRS990ScheduleF/ContinuationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt0106164
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt0WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0SUBCONTRACT ON CEGS NIH GRANT
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0EUROPE(INCLUDING ICELAND AND GREENLAND)
IRS990ScheduleF/InterestInForeignTrustInd00
IRS990ScheduleF/PassiveForeignInvestmestCoInd00
IRS990ScheduleF/SubtotalEmployeesCnt00
IRS990ScheduleF/SubtotalOfficesCnt00
IRS990ScheduleF/SubtotalSpentAmt0106164
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt0LUDWIG MAXIMILIANS-UNIVERSITAT (LMU) IS A SUB-RECIPIENT OF THE NATIONAL INSTITUTE OF HEALTH GRANT FOR CEGS. THEY WERE ONBOARDED AND ARE MONITORED LIKE OUR OTHER SUB-RECIPIENTS IN THE UNITED STATES. ALTIUS HAS A PROCEDURE THAT CONFORMS WITH THE UNIFORM GUIDANCE WHEN WE ENGAGE/ONBOARD/MONITOR SUB-RECIPIENTS. THE LEGAL CONTRACT TEAM ALSO REVIEWS THE SUB-RECIPIENT AWARD AND ASKS PERTINENT QUESTIONS.
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt1THE EXPENDITURES REPORTED ON SCHEDULE F, PART I, LINE 3 ARE ON THE ACCRUAL BASIS OF ACCOUNTING.
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc0PART I, LINE 2:
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc1PART I, LINE 3:
IRS990ScheduleF/Total501c3OrgCnt01
IRS990ScheduleF/TotalEmployeeCnt00
IRS990ScheduleF/TotalOfficeCnt00
IRS990ScheduleF/TotalOtherOrgCnt00
IRS990ScheduleF/TotalSpentAmt0106164
IRS990ScheduleF/TransferToForeignCorpInd00
IRS990ScheduleJ/AnyNonFixedPaymentsInd00
IRS990ScheduleJ/BoardOrCommitteeApprovalInd0X
IRS990ScheduleJ/CompBasedOnRevenueOfFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsRltdOrgsInd00
IRS990ScheduleJ/CompBsdOnRevRelatedOrgsInd00
IRS990ScheduleJ/CompensationCommitteeInd0X

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2018 filings • 501(c)3 • $10M-$25M nonprofits